Table 1 Demographic characteristics and comorbidities in patients with and without ESRD
From: Increased risk of deep vein thrombosis in end-stage renal disease patients
Non-ESRD (n = 5094) | ESRD (n = 3564) | |
|---|---|---|
Age | ||
≦39 | 412 (8.1a) | 265 (7.4) |
40–49 | 677 (13.3) | 406 (11.4) |
50–59 | 1137 (22.3) | 772 (21.7) |
60–69 | 1180 (23.2) | 849 (23.8) |
≧70 | 1688 (33.1) | 1272 (35.7) |
Mean ± SD | 61.84 ± 15.00 | 62.76 ± 14.69 |
Gender | ||
Male | 2499 (49.1) | 1762 (49.4) |
Female | 2595 (50.9) | 1802 (50.6) |
Deep vein thrombosis | 26 (0.5) | 200 (5.6) |
Comorbidities | ||
Atrial fibrillation | 24 (0.5) | 64 (1.8) |
Hypertension | 1369 (26.9) | 2024 (56.8) |
Diabetes | 684 (13.4) | 1404 (39.4) |
Hyperlipidemia | 63 (1.2) | 208 (5.8) |
Cerebrovascular accident | 135 (2.7) | 394 (11.1) |
Congestive heart failure | 65 (1.3) | 616 (17.3) |
Lower leg fracture or surgery | 28 (0.5) | 44 (1.2) |
Cancer | 99 (1.9) | 82 (2.3) |